Sepsis & AMR · Oct 2026 · 5 min read · By Laboratory House
In suspected bloodstream infection, knowing the organism and key resistance genes early supports more targeted antibiotic choices. Blood culture PCR panels shorten the gap between a positive bottle and a useful answer.
The timing problem
When a blood culture bottle flags positive, Gram stain gives a first clue, but identification and susceptibility results from subculture can take a further day or more. During that time patients are usually on broad-spectrum antibiotics chosen without knowing the organism.
What the panels detect
Blood culture panels can identify common bacteria and fungi and detect resistance markers from a positive blood culture. Examples include:
- mecA, associated with methicillin resistance in staphylococci
- vanA / vanB, associated with vancomycin resistance in enterococci
- Carbapenemase genes, for example NDM, KPC, OXA-48 and VIM, in Gram-negative bacteria
On the Ultra Multiplex system there are separate Blood Culture G+ / Fungal + AMR and Blood Culture G− + AMR panels, with 25 and 27 targets respectively.
Supporting antimicrobial stewardship
Early knowledge of a resistance gene can prompt a change to a more suitable agent sooner, or allow a clinician to narrow therapy when no resistance marker is found. This supports stewardship alongside routine susceptibility testing, which remains essential.
Cautions
A resistance gene does not always predict phenotypic resistance, and the absence of a tested gene does not exclude resistance by another mechanism. Results should always be confirmed and interpreted by the treating team and the microbiology laboratory.
Learn more about molecular and syndromic testing, or book a demonstration for your microbiology lab.
For healthcare professionals. Educational content only; not a substitute for clinical judgement. Product regulatory status is as per the principal’s approvals.
